Things you’ll learn in this article:

• What Andrew Huberman has actually said about BPC-157 on the Huberman Lab Podcast
• Why his statements sparked debate among doctors and peptide specialists
• What Joe Rogan’s peptide use has to do with the discussion
• Common questions about BPC-157 safety, usage, and effects
• Why Huberman’s concerns about cancer risk are theoretical, not proven

Why everyone’s talking about Andrew Huberman and BPC-157

If you’ve spent any time in the wellness or performance space lately, you’ve probably seen peptides pop up in conversations between Andrew Huberman and Joe Rogan. But when it comes to the highly popular peptide BPC-157, there’s a lot of confusion about his stance. Did he endorse it? Did he warn against it?

Dr. Huberman, a Stanford neuroscientist and host of the Huberman Lab Podcast, is one of the most respected voices bringing complex science to the public. He discussed BPC-157 and other peptides as part of a broader conversation on regenerative biology and recovery. But while some listeners walked away thinking he endorsed the peptide, Huberman’s position is much more nuanced.

Let’s break down what he’s really said and what he hasn’t.

What Andrew Huberman said about BPC-157

Huberman has spoken openly about his personal experience with BPC-157. In a podcast episode on peptide therapeutics (April 2024), he shared that he once suffered an L5 compression injury that caused persistent pain. According to him, the pain improved dramatically after two injections of BPC-157.

He used this anecdote to explain how peptides like BPC-157 may help the body repair tissues through mechanisms such as:

• Angiogenesis: promoting new blood vessel growth to bring nutrients to injured areas
• Fibroblast migration: helping connective tissue and tendons regenerate
• Anti-inflammatory signaling: reducing pain and swelling during recovery

Despite his positive experience, Huberman stopped short of endorsing BPC-157 or recommending its use. Instead, he repeatedly emphasized the need for:

• Medical supervision
• Reputable sourcing (since the market is “rife with dubious products”)
• Caution until more human research is available

In his words, peptide therapy “sits somewhere between dietary supplements and prescription drugs,” meaning it doesn’t fit neatly into standard medical categories.

What Huberman has not said about BPC-157

It’s important to separate fact from internet speculation. Here’s what Huberman has not said:

• He has not endorsed BPC-157 as safe or effective for everyone
• He has not suggested taking peptides without medical oversight
• He has not dismissed the need for more research or human trials

In short, while Huberman’s discussion helped raise awareness of BPC-157, he continues to urge listeners to be careful with any unregulated compound, no matter how promising it sounds.

Huberman’s caution: the theoretical cancer risk

One of Huberman’s most debated comments involved a potential cancer risk tied to peptides that promote angiogenesis (blood vessel growth). His reasoning: if a substance stimulates new blood vessel formation, it could theoretically also feed unwanted cell growth, including tumors.

Huberman’s caution wasn’t based on any known cases of harm—it was a theoretical risk grounded in biological logic. Still, this comment quickly became controversial online.

How experts responded:

• Selective angiogenesis: Doctors like Dr. Kent Holtorf and Dr. Stephanie Rimka pointed out that BPC-157 doesn’t promote random blood vessel growth everywhere. It seems to target injured tissues only.
• Anti-cancer findings: Research summarized in Ortho and Wellness Journal and PMC/NIH reviews suggest BPC-157 may even suppress tumor growth by reducing inflammation and controlling abnormal cell proliferation.
• Context matters: Experts note that if Huberman’s logic were applied broadly, antioxidants like vitamin C or NAC, both of which influence angiogenesis would also appear risky, even though they have protective effects.

In other words, Huberman’s warning was a reasonable precaution, but not definitive evidence of danger.

What happens when you take BPC-157?

Research suggests BPC-157 may support the body’s natural healing processes. Reported effects include:

• Less pain from tendon, ligament, or muscle injuries
• Faster recovery after training
• Improved joint mobility

Animal studies show BPC-157 may speed up blood vessel formation, cell regeneration, and inflammation control in damaged tissues. Users typically notice effects within a few days to weeks of consistent use, though individual results vary.

Can BPC-157 cause liver damage?

Surprisingly, studies suggest BPC-157 protects the liver rather than harms it. A 1993 Life Sciences paper available on PubMed found that the peptide reduced liver necrosis and stress-induced injury in animal models. More recently, a 2025 review in the Journal of Clinical Medicine found no evidence of liver or kidney toxicity.

Researchers instead observed hepatoprotective effects, meaning it may help maintain healthy enzyme function during oxidative stress.

Why do bodybuilders take BPC-157?

Bodybuilders often use BPC-157 to help recover from joint and tendon strain, especially during or after steroid cycles. Some reasons include:

• Faster tissue repair after intense training
• Reduced inflammation in overused joints
• Support for post-cycle recovery when hormone levels drop

It’s not about building muscle directly. It’s about protecting connective tissue so they can keep training at high intensity.

Can I take BPC-157 every day?

Most practitioners recommend daily use during short cycles, typically 4 to 8 weeks, then taking breaks. This pattern helps the body respond better and avoids potential receptor desensitization.

Research suggests a “bell-shaped” dose response, meaning more is not always better. Typical guidance involves moderate, consistent use rather than high or indefinite dosing.

However, because human studies are still limited, it’s best to consult a healthcare provider before starting any peptide regimen.

Can BPC-157 affect your heart?

So far, studies suggest cardioprotective benefits, not harm. In animal models, BPC-157:

• Improved blood vessel dilation
• Reduced arrhythmias
• Protected heart tissue after restricted blood flow (ischemia)

No evidence has shown cardiac toxicity or adverse effects on heart rhythm.

What happens if I stop taking peptides?

Unlike hormone replacement therapy, stopping BPC-157 doesn’t cause withdrawal or rebound symptoms.

Once discontinued, the peptide simply leaves the body, and healing benefits gradually stabilize. Tissues that have repaired typically remain improved, though new injuries will heal at the body’s natural pace.

That said, Huberman and other experts suggest cycling peptides to give receptors time to reset between uses.

The Takeaway: Huberman is cautious, not dismissive

To sum it up, Andrew Huberman’s stance on BPC-157 is balanced:

• He acknowledges its potential and even shares a positive personal experience.
• He also emphasizes caution, sourcing, and supervision, reminding listeners that peptide science is still evolving.
• His theoretical cancer warning sparked debate, but there’s no confirmed evidence of harm in humans.

While Huberman has helped bring peptides like BPC-157 into mainstream discussion, he ultimately urges curiosity with caution, a message worth repeating.

Disclaimer: This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any supplement or peptide therapy.

Sources

• Benefits and Risks of Peptide Therapeutics – Huberman Lab
• Top Doctors Tackle Huberman’s Claims on BPC-157 and Cancer – Human Longevity Institute
• Is Joe Rogan Right About BPC-157? – Liquid Mobile IV
• What Is BPC-157? – The Piazza Center
• PubMed: Hepatoprotective Effect of BPC-157
• Medisearch: Is BPC-157 Bad for Your Heart?
• Swolverine: The Ultimate Guide to a BPC-157 Cycle for Joint and Muscle Recovery